The evaluation of white matter lesion progression is an important biomarker in the follow-up of MS patients and plays a crucial role when deciding the course of treatment. Current automated lesion segmentation algorithms are susceptible to variability in image characteristics related to MRI scanner or protocol differences. We propose a model that improves the consistency of MS lesion segmentations in inter-scanner studies. First, we train a CNN base model to approximate the performance of icobrain, an FDA-approved clinically available lesion segmentation software. A discriminator model is then trained to predict if two lesion segmentations are based on scans acquired using the same scanner type or not, achieving a 78% accuracy in this task. Finally, the base model and the discriminator are trained adversarially on multi-scanner longitudinal data to improve the inter-scanner consistency of the base model. The performance of the models is evaluated on an unseen dataset containing manual delineations. The inter-scanner variability is evaluated on test-retest data, where the adversarial network produces improved results over the base model and the FDA-approved solution.
View on arXiv